CSI Market
Sign In | Register

Oasmia Pharmaceutical Ab (OASM) Annual Income Statement

Annual · GAAP · USD millions
Access OASM quarterly income statements →
This page allows investors to track Oasmia Pharmaceutical Ab's income statement performance across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Apr 30 2018)
2018
Revenues
Total Revenue3.17
Costs & Expenses
Gross Profit0.00
OtherOperating Income Expense223.25
Total operating costs including COS12.88
Operating income / -loss-12.50
Net Interest (-)Expense / Income0.00
Other loss / -income-132.30
Total costs & expenses121.18
Income & Taxes
Income / -loss before income taxes-118.01
Income after income taxes-118.01
Income / -loss from continuing operations-14.22
Non-controlling interests-118.01
Net income / -loss-118.01
Income / -loss to shareholder-14.22
EBIT-118.01
EBITD-118.01
EBITDA-118.01
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Basic shares outstanding (Mill. of Units)166.20
Diluted Net EPS0.00
Diluted average shares (Mill. of Units)166.20
4 historic quarters locked

Sign in to unlock the full Oasmia Pharmaceutical Ab income statement history.

Sign In Create Free Account

About OASM Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.